Commentary: HeartWare HVAD to HeartMate 3 Device Exchange: Assessing the Technical Challenges

  • Francis D. Pagani
    Address reprint requests to Francis D. Pagani, Department of Cardiac Surgery, 5161 Cardiovascular Center, 1500 East Medical Center Drive, SPC 5864, University of Michigan, Ann Arbor, MI 48109.
    Department of Cardiac Surgery, University of Michigan, Ann Arbor, MI
    Search for articles by this author

      Central Picture

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Operative Techniques in Thoracic and Cardiovascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Aaronson KD
        • Slaughter MS
        • Miller LW
        • et al.
        Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation.
        Circulation. 2012; 125: 3191-3200
        • Schmitto JD
        • Zimpfer D
        • Fiane AE
        • et al.
        Long-term support of patients receiving a left ventricular assist device for advanced heart failure: A follow-up analysis of the Registry to Evaluate the HeartWare Left Ventricular Assist System.
        Eur J Cardiothorac Surg. 2016; 50: 834-838
        • Slaughter MS
        • Pagani FD
        • McGee EC
        • et al.
        HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial.
        J Heart Lung Transplant. 2013; 32: 675-683
        • Rogers JG
        • Pagani FD
        • Tatooles AJ
        • et al.
        Intrapericardial left ventricular assist device for advanced heart failure.
        N Engl J Med. 2017; 376: 451-460
        • Milano CA
        • Rogers JG
        • Tatooles AJ
        • et al.
        HVAD: The ENDURANCE supplemental trial.
        JACC Heart Fail. 2018; 6: 792-802
        • Teuteberg JJ
        • Cleveland Jr, JC
        • Cowger J
        • et al.
        The Society of Thoracic Surgeons Intermacs 2019 Annual report: The changing landscape of devices and indications.
        Ann Thorac Surg. 2020; 109: 649-660
      1. Medtronic Recalls HVAD Pump Implant Kits Due to Delayed or Failed Restart After the Pump is Stopped. U.S. Food and Drug Administration Website. Date accessed: July 7, 2021.

        • Pagani FD
        • Cantor R
        • Cowger J
        Concordance of treatment effect: An analysis of The Society of Thoracic Surgeons Intermacs Database.
        Ann Thorac Surg. 2022; 113: 1172-1182
        • Cho SM
        • Mehaffey JH
        • Meyers SL
        • et al.
        Cerebrovascular events in patients with centrifugal-flow left ventricular assist devices: Propensity score-matched analysis from the Intermacs registry.
        Circulation. 2021; 144: 763-772
        • Salerno CT
        • Hayward C
        • Hall S
        HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations.
        J Thorac Cardiovasc Surg. 2022; 163: 2120-2127
        • Hayward C
        • Adachi I
        • Baudart S
        Global best practices consensus: Long-term management of patients with hybrid centrifugal flow left ventricular assist device support.
        J Thorac Cardiovasc Surg. 2022; 164: 1120-1137
        • Lam VH
        • Rafael-Yarihuaman AE
        • Meyer DM.
        HeartWare HVAD exchange to HeartMate 3: Principles, techniques, and pitfalls.
        Op Tech Thorac Cardiovasc Surg. 2022; xx: xxx
        • Hanke JS
        • Haverich A
        • Schmitto JD.
        Exchange of a HeartWare HVAD to a HeartMate 3 left 380 ventricular assist device.
        J Heart Lung Transplant. 2017; 36: 480-481
        • Hanke JS
        • Rojas SV
        • Dogan G
        • et al.
        First series of left ventricular assist device exchanges to 383 HeartMate 3.
        Eur J Cardiothorac Surg. 2017; 51: 887-892
        • Hanke JS
        • Dogan G
        • Haverich A
        • Schmitto JD.
        Exchange of a HeartMate 3 left ventricular assist 396 device through thoracotomy.
        Oper Tech Thorac Cardiovasc Surg. 2018; 23: 62-75
        • Hanke JS
        • Mariani S
        • Merzah AS
        • et al.
        Three year follow-up after less-invasive Left Ventricular 399 Assist Device exchange to HeartMate 3.
        J Cardiovasc Surg (Torino). 2021 May 31; (doi: 400)
        • Bourque K
        • Martin MJ
        • Harjes DI
        • Cassidy DL
        • Pagani FD
        • Kormos RL.
        Graft resistance difference after HVAD to HeartMate 3 left ventricular assist device exchange.
        Ann Thorac Surg. 2022; (S0003-4975(21)02170-6)

      Linked Article

      • HeartWare HVAD Exchange to HeartMate3: Principles, Techniques, and Pitfalls
        Operative Techniques in Thoracic and Cardiovascular Surgery
        • Preview
          Since the recall of the HeartWare HVAD device in 2021, the management of the remaining implants range from medical management, transplant, to exchange. This article describes 2 feasible approaches to exchange the HVAD to the HeartMate3 device through a combination of a left lateral thoracotomy with a superior hemi-sternotomy. These approaches minimize dissection and complications of a redo-sternotomy and minimizes bypass time. Pitfalls and solutions are also herein described.
        • Full-Text
        • PDF